Provider motivations and barriers to cancer clinical trial screening, referral, and operations: Findings from a survey.
Kelly DurdenPatricia HurleyDorothy L ButlerAmy FarnerSharon P ShriverMark E FleuryPublished in: Cancer (2023)
There are many factors that contribute to low adult enrollment in cancer clinical trials, but previous research has indicated that provider and institutional barriers are the largest contributors to low cancer clinical trial enrollment. In this survey, we sought to gain insight into cancer clinical trial enrollment practices from the perspective of health care providers such as physicians and nurses. We found that only approximately half of respondents indicated their institution systematically screens their patients for clinical trials and this process is manual and time consuming. Furthermore, we found that providers infrequently search for and refer patients to clinical trials at other sites. Creating better screening methods could improve enrollment in clinical trials.
Keyphrases
- clinical trial
- papillary thyroid
- healthcare
- primary care
- phase ii
- squamous cell
- open label
- ejection fraction
- newly diagnosed
- double blind
- study protocol
- phase iii
- health insurance
- childhood cancer
- lymph node metastasis
- genome wide
- gene expression
- prognostic factors
- randomized controlled trial
- squamous cell carcinoma
- young adults
- patient reported
- dna methylation